Chase Investment Counsel Corp. »

United Therapeutics Corporation shares owned by Chase Investment Counsel Corp.

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Chase Investment Counsel Corp. from 13F filings

Historical chart of Chase Investment Counsel Corp. investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Chase Investment Counsel Corp. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Chase Investment Counsel Corp.

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.8M 4.4k 419.09
2025-06-30 $1.7M 5.8k 287.27
2025-03-31 $1.7M 5.4k 308.09
2024-12-31 $485k 1.4k 352.73
2024-09-30 $492k 1.4k 357.82

More positions owned by Chase Investment Counsel Corp.

NVIDIA Corporation (NVDA)
Celestica (CLS)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Vertiv Holdings Com Cl A (VRT)
Bank of New York Mellon Corporation (BK)
Goldman Sachs (GS)
eBay (EBAY)
Agnico (AEM)
Abbvie (ABBV)
Howmet Aerospace (HWM)
Amazon (AMZN)
National Fuel Gas (NFG)
Capital One Financial (COF)

View all positions for Chase Investment Counsel Corp.

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation